
EDAP TMS S.A. EDAP
$ 3.88
-4.43%
Quarterly report 2024-Q4
added 03-07-2026
Country |
|
IPO year |
1997 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
37.3 M |
Market Cap[1] |
$ 145 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
$ 2.2 | -0.9 % | $ 3.43 M | Nasdaq Capital Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 10.58 | 1.24 % | $ 1.43 B | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 9.61 | -13.93 % | $ 272 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 12.79 | -2.07 % | $ 1.92 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.65 | -4.4 % | $ 35.4 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 8.34 | -0.24 % | $ 599 M | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Butterfly Network
BFLY
|
$ 4.05 | -5.27 % | $ 857 M | NYSE | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Boston Scientific Corporation
BSX
|
$ 71.56 | 0.51 % | $ 106 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
CONMED Corporation
CNMD
|
$ 36.91 | -1.15 % | $ 1.15 B | NYSE,SPB | ||
|
Establishment Labs Holdings
ESTA
|
$ 64.97 | -0.06 % | $ 1.92 B | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
InMode Ltd.
INMD
|
$ 13.5 | -1.1 % | $ 873 M | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.33 | - | $ 21.5 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.68 | -3.08 % | $ 391 M | Nasdaq Global Select Market,SPB | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.44 | -0.05 % | $ 121 M | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Abbott Laboratories
ABT
|
$ 108.24 | -2.23 % | $ 188 B | NYSE,SPB | ||
|
Delcath Systems
DCTH
|
$ 9.45 | -2.97 % | $ 339 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 269.28 | -0.07 % | $ 7.6 B | NYSE,SPB | ||
|
Myomo
MYO
|
$ 0.7 | -2.52 % | $ 29.3 M | NYSE American | ||
|
Helius Medical Technologies
HSDT
|
$ 2.09 | -3.69 % | $ 1.27 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 31.01 | -5.33 % | $ 1.43 B | Nasdaq Capital Market,SPB | ||
|
Align Technology
ALGN
|
$ 173.34 | -1.58 % | $ 13 B | Nasdaq Global Select Market,SPB | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 8.9 | -2.2 % | $ 685 M | Nasdaq Global Select Market,SPB | ||
|
Bruker Corporation
BRKR
|
$ 34.48 | 2.18 % | $ 5.14 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Apyx Medical Corporation
APYX
|
$ 3.71 | -0.94 % | $ 152 M | Nasdaq Global Select Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.42 | 8.36 % | $ 43.2 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.